Licensing & Regulatory Boards

Colorado Division of Professions and Occupations program overseeing facilitator licensing, renewals, complaints, and rule/policy resources for natural medicine services.

Colorado Department of Revenue division responsible for licensing and regulating natural medicine businesses, including healing centers, cultivations, product manufacturers, and testing facilities.

The Colorado Natural Medicine Advisory Board is a statutorily created state board within Colorado’s Division of Professions and Occupations that advises the state licensing authority on implementing Colorado’s natural medicine regulatory program. It operates in Colorado and serves statewide public interests, with board membership drawn to reflect expertise in natural medicine, research, cultivation, public health, insurance, behavioral health, veterans, Indigenous use, and criminal justice reform. Its core work is to make recommendations on rules, public education, training, facilitator qualifications, data collection, and access considerations. In Colorado’s regulated natural medicine system, the board functions as an implementation and oversight working group rather than a direct service provider or advocacy nonprofit. Documented current activity includes recommending state action on ibogaine sourcing and cultural protocols, including alignment with the Nagoya Protocol and a federal Controlled Substances Act waiver request for import pathways. Its role in the field is to shape how regulated access is designed, safer use information is communicated, and whether additional natural medicines or insurance coverage considerations should be evaluated over time.

The European Medicines Agency is a decentralised agency of the European Union. It coordinates the scientific evaluation, supervision and safety monitoring of medicines for human and veterinary use across the EU. Its headquarters are in Amsterdam, the Netherlands.

The Medicines and Healthcare products Regulatory Agency is a UK government agency that regulates medicines, medical devices and blood components for transfusion. It also supports public health by assessing the safety, quality and efficacy of healthcare products, and by enabling innovation and research. Its contact address is in Canary Wharf, London.

State advisory board established under New Mexico medical psilocybin policy to guide program standards, implementation recommendations, and evidence-informed regulatory development.

Oregon Health Authority is a state government agency in Oregon. Its Oregon Psilocybin Services section regulates psilocybin services in the state, including licensing and compliance for the legal framework created by Oregon Measure 109.

Oregon state education regulator that licenses private career schools and oversees approval pathways relevant to psilocybin facilitator training program operations in Oregon.

The Oregon Psilocybin Advisory Board is a state advisory body within the Oregon Health Authority that operates in Oregon. It was established under Oregon law to make recommendations on scientific evidence, safety and efficacy, and the requirements, specifications, and guidelines for psilocybin services in the state. Its work is oriented toward public meetings, advisory recommendations, and related subcommittee and workgroup processes. In Oregon's regulated psilocybin system, the board functions as an implementation and policy guidance group rather than a direct service provider. Source materials show it has produced evidence reviews and has supported ongoing advisory and workgroup activity tied to psilocybin service rules, product issues, and public comment opportunities. Potential collaboration areas include regulatory implementation, evidence review, clinical and facilitator standards, public health safeguards, and access-oriented policy feedback from researchers, clinicians, funders, and patient or community stakeholders.

Swiss federal authority issuing exceptional licences for otherwise prohibited narcotics, including controlled pathways relevant to psychedelic substances under medical/scientific exceptions.